Literature DB >> 24698433

Overcoming the current deadlock in antibiotic research.

Till F Schäberle1, Ingrid M Hack2.   

Abstract

Antibiotic-resistant bacteria are on the rise, making it harder to treat bacterial infections. The situation is aggravated by the shrinking of the antibiotic development pipeline. To finance urgently needed incentives for antibiotic research, creative financing solutions are needed. Public-private partnerships (PPPs) are a successful model for moving forward.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  antibiotic resistance; public health; public–private partnership (PPP)

Mesh:

Substances:

Year:  2014        PMID: 24698433     DOI: 10.1016/j.tim.2013.12.007

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  34 in total

1.  Nanomedicine in the Management of Microbial Infection - Overview and Perspectives.

Authors:  Xi Zhu; Aleksandar F Radovic-Moreno; Jun Wu; Robert Langer; Jinjun Shi
Journal:  Nano Today       Date:  2014-08-01       Impact factor: 20.722

2.  Intracellular localization of polymyxins in human alveolar epithelial cells.

Authors:  Maizbha U Ahmed; Tony Velkov; Qi Tony Zhou; Alex J Fulcher; Judy Callaghan; Fanfan Zhou; Kim Chan; Mohammad A K Azad; Jian Li
Journal:  J Antimicrob Chemother       Date:  2019-01-01       Impact factor: 5.790

3.  Docking and molecular dynamics studies on triclosan derivatives binding to FabI.

Authors:  Xuyun Yang; Junrui Lu; Ming Ying; Jiangbei Mu; Peichun Li; Yue Liu
Journal:  J Mol Model       Date:  2017-01-07       Impact factor: 1.810

Review 4.  Virulence Factor Targeting of the Bacterial Pathogen Staphylococcus aureus for Vaccine and Therapeutics.

Authors:  Trevor L Kane; Katelyn E Carothers; Shaun W Lee
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

5.  Experimental Evolution of Diverse Strains as a Method for the Determination of Biochemical Mechanisms of Action for Novel Pyrrolizidinone Antibiotics.

Authors:  Kathryn Beabout; Megan D McCurry; Heer Mehta; Akshay A Shah; Kiran Kumar Pulukuri; Stephan Rigol; Yanping Wang; K C Nicolaou; Yousif Shamoo
Journal:  ACS Infect Dis       Date:  2017-09-27       Impact factor: 5.084

6.  Repurposing salicylamide for combating multidrug-resistant Neisseria gonorrhoeae.

Authors:  Marwa Alhashimi; Abdelrahman Mayhoub; Mohamed N Seleem
Journal:  Antimicrob Agents Chemother       Date:  2019-09-30       Impact factor: 5.191

7.  The bacterial type III secretion system as a target for developing new antibiotics.

Authors:  Andrew C McShan; Roberto N De Guzman
Journal:  Chem Biol Drug Des       Date:  2015-01       Impact factor: 2.817

8.  Dual Targeting of Cell Wall Precursors by Teixobactin Leads to Cell Lysis.

Authors:  Tomoyuki Homma; Austin Nuxoll; Autumn Brown Gandt; Patrick Ebner; Ina Engels; Tanja Schneider; Friedrich Götz; Kim Lewis; Brian P Conlon
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

Review 9.  Steering Phages to Combat Bacterial Pathogens.

Authors:  James Gurney; Sam P Brown; Oliver Kaltz; Michael E Hochberg
Journal:  Trends Microbiol       Date:  2019-11-16       Impact factor: 17.079

Review 10.  Harnessing bacterial interactions to manage infections: a review on the opportunistic pathogen Pseudomonas aeruginosa as a case example.

Authors:  Chiara Rezzoagli; Elisa T Granato; Rolf Kümmerli
Journal:  J Med Microbiol       Date:  2020-01-21       Impact factor: 2.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.